Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04384354
Other study ID # DIGDMD
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2007
Est. completion date April 2019

Study information

Verified date May 2020
Source Centre d'Investigation Clinique et Technologique 805
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Relation between clinical and genetic features and acute digestive events in Duchenne muscular dystrophy patients


Description:

Clinical Data of the disease Digestive events (pseudo occlusion, gastrostomy, cholecystectomy) Nutritionnal parameters Genetic of dystrophin (approved genetic nationnal Data base, CHU Cochin, Paris France)


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date April 2019
Est. primary completion date December 2018
Accepts healthy volunteers
Gender Male
Age group 15 Years and older
Eligibility Inclusion Criteria:

- all Duchenne muscular dystrophy patients in our center

Exclusion Criteria:

- none

Study Design


Locations

Country Name City State
France CICIT805 Garches

Sponsors (1)

Lead Sponsor Collaborator
Centre d'Investigation Clinique et Technologique 805

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of digestive events Clinical parameters (yes or no): gastrostomy, bowel occlusion, acute gastric paresia, biliary complication 11 years
Primary Prevalence of digestive events Clinical parameters (yes or no) : gastrostomy, bowel occlusion, acute gastric paresia, biliary complication 11 years
Primary Risk factors for digestive events (1) age (years) 11 years
Primary Risk factors for digestive events (2) pulmonary functional tests (vital capacity in ml/kg) 11 years
Primary Risk factors for digestive events (3) echocardiography parameters (LVEF: left ventricular ejection fraction in %) 11 years
Primary Risk factors for digestive events (4) residual dystrophin level (Western blot and/or immunohistochemistry in muscle) 11 years
Primary Risks factors for digestive events (5) genetic parameters (type of mutation, functional domain of altered dystrophin) 11 years
Secondary Nutritional status (1) Weigh (kg) and height (in m) agregated in BMI (kg/m^2) 11 years
Secondary Nutritional status (2) albuminemia in g/L 11 years
See also
  Status Clinical Trial Phase
Completed NCT05575648 - Dual Task in Duchenne Muscular Dystrophy N/A
Terminated NCT03907072 - Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy Phase 2/Phase 3
Not yet recruiting NCT06450639 - An Open-label Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy Phase 2
Completed NCT04335942 - Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor N/A
Active, not recruiting NCT04906460 - Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53) Phase 1/Phase 2
Active, not recruiting NCT02500381 - Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) Phase 3
Enrolling by invitation NCT05967351 - A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study Phase 3
Recruiting NCT03067831 - Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy Phase 1/Phase 2
Recruiting NCT01834040 - Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy Phase 1/Phase 2
Completed NCT02246478 - A Study of TAS-205 for Duchenne Muscular Dystrophy Phase 1
Active, not recruiting NCT01772043 - Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping N/A
Terminated NCT01168908 - Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Phase 2
Completed NCT00758225 - Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension) Phase 2
Completed NCT03680365 - Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
Recruiting NCT03513367 - The Validation Process for Confirmation of the French Version of the Pediatric Quality of Life Inventory :PedsQLTM.
Recruiting NCT05712447 - Duchenne Muscular Dystrophy Video Assessment Registry
Recruiting NCT01484678 - Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
Completed NCT03319030 - Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD)
Terminated NCT01753804 - A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy. N/A
Completed NCT02530905 - Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients Phase 1